multiple mesenchym stemstrom cell msc posse robust selfrenew characters bail different tissuespecif therapeutic potent appear promise revid efficacy sever anim model pulmonary discord well earlyphas clinic trial act respiratory distress syndrome ard chronic obstruct disease copy might attribute mscderiv product secret name conduit medium cm extracellular vesicle ev shown play pivot role rgen function importantly secret transfer variety bioactiv factor model recipe via various meghan include ligandreceptor interact direct membrane fusion endocytosi phagocytosi herein review current stateofthesci agent lung disease suggest appropri agent treat address biology list advantage live cell therapy nonetheless studi warrant lucid safety common combat 